Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates

B Bohrmann1, M Adrian, J Dubochet

  • 1Pharma Division, F. Hoffmann-La Roche AG, Basel, CH-4070, Switzerland. bernd.bohrmann@roche.com

Insights

Researchers identified a novel polymeric sheet structure during amyloid-beta (Abeta) assembly, a key process in Alzheimer's disease (AD). A compound, Ro 90-7501, was found to inhibit Abeta fibril formation, offering a potential therapeutic strategy for AD.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Structural Biology

Background:

  • Alzheimer's disease (AD) pathogenesis is linked to amyloid-beta (Abeta) peptide aggregation into fibrils.
  • Inhibiting Abeta fibril assembly presents a promising therapeutic avenue for AD.

Purpose of the Study:

  • To investigate the initial native assembly structure of Abeta42 using electron cryomicroscopy.
  • To identify compounds that reduce Abeta42-induced toxicity and inhibit fibril formation.

Main Methods:

  • Electron cryomicroscopy to visualize Abeta42 assembly intermediates.
  • Cell-based screening assay to identify toxicity-reducing compounds.
  • Assays for compound binding, radical scavenging, and influence on Abeta42 assembly.

Main Results:

  • A nonfibrillar, polymeric Abeta42 sheet structure was identified alongside known fibrillar intermediates.
  • A temporal sequence of assembly was observed: sheets, then intermediates, then mature fibrils.
  • Compound Ro 90-7501 inhibited mature fibril formation, accumulating earlier structures.

Conclusions:

  • Abeta assembly involves a transient polymeric sheet intermediate.
  • Ro 90-7501 acts as a prototypic inhibitor of Abeta42 fibril formation.
  • This compound can be a tool for studying the molecular mechanisms of Abeta assembly.

Related Concept Videos

Protein Folding01:22

Protein Folding

Overview
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...